Chile vs Kazakhstan: Treatment success rate: XDR-TB cases
Chile
75
in 2022
Kazakhstan
75
in 2022
Chile rank
29th
Kazakhstan rank
29th
Treatment success rate: XDR-TB cases over time
- Chile
- Kazakhstan
How they compare
Chile currently reports 75 against 75 in Kazakhstan, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was Kazakhstan ahead.
Chile ranks 29th and Kazakhstan ranks 29th of 82 countries.
Across the 2 decades both report, Chile averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Chile | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 40 | 74.5 | 34.5 | Kazakhstan |
| 2020s | 85 | 76.67 | 8.33 | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Chile or Kazakhstan?
- Chile, at 75 against 75 in Kazakhstan as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Chile and Kazakhstan?
- 0, with Chile ahead.
- How many years of comparable data are there for Chile and Kazakhstan?
- 5 years are reported by both, from 2018 to 2022.
- How do Chile and Kazakhstan rank globally for treatment success rate: xdr-tb cases?
- Chile ranks 29th and Kazakhstan ranks 29th of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.